Article Information
History
- November 24, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Carlo S R Araujo*,1,
- Ana C Medeiros-Ribeiro*,1,
- Carla G S Saad1,
- Karina R Bonfiglioli1,
- Diogo S Domiciano1,
- Andrea Y Shimabuco1,
- Matheus R Silva1,
- Emily F N Yuki1,
- Sandra G Pasoto1,
- Tatiana N Pedrosa1,
- Leonard Kupa1,
- Gioanna Zou1,
- Rosa M R Pereira1,
- Clovis A Silva2,
- Nadia E Aikawa1,2 and
- Eloisa Bonfa1,†
- 1Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil
- 2Pediatric Rheumatology Unit, Instituto da Criança, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil
- ↵†Corresponding author:
Prof. Eloisa Bonfa, M.D., Ph.D., Av. Dr. Arnaldo, 455, sala 3190 - Cerqueira César, São Paulo – SP – Brazil, ZIP-code 01246-903, E-mail – eloisa.bonfa{at}hc.fm.usp.br
↵* These authors contributed equally: Carlo S R Araujo, Ana C. Medeiros-Ribeiro
Posted November 24, 2021.
A RANDOMIZED CLINICAL TRIAL OF 2-WEEK METHOTREXATE DISCONTINUATION IN RHEUMATOID ARTHRITIS PATIENTS VACCINATED WITH INACTIVATED SARS-COV-2 VACCINE
